peptide receptor radionuclide therapy

You have access
Identification of Wandering Masses and Tumor Heterogeneity on ⁶⁸Ga-DOTATATE and ¹⁸F-FDG PET/CT in Metastatic Grade II Neuroendocrine Tumor with Increased Somatostatin Receptor Expression After Combined Chemotherapy and PRRT
Parth Baberwal, Rahul Parghane and Sandip Basu

Journal of Nuclear Medicine Technology September 1, 2024, 52 (3) 272-273; DOI: https://doi.org/10.2967/jnmt.123.267286
You have access
Imaging Pathway of a Pediatric Patient with Succinate Dehydrogenase B-Deficient Paraganglioma
Stephen Edmonds, Jennifer Davidson, Rosanne Joseph and Madhusudan Vyas

Journal of Nuclear Medicine Technology December 1, 2023, 51 (4) 318-322; DOI: https://doi.org/10.2967/jnmt.123.265655
You have access
Discordance Between Histopathologic Grading and Dual-Tracer PET/CT Findings in Metastatic NETs and Outcome of ¹⁷⁷Lu-DOTATATE PRRT: Does In Vivo Molecular PET Perform Better from the Viewpoint of Prediction of Tumor Biology?
Aadil Adnan and Sandip Basu

Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 248-255; DOI: https://doi.org/10.2967/jnmt.121.261998
You have access
Occurrence of the Redifferentiation-Akin Phenomenon on ⁶⁸Ga-DOTATATE PET/CT After CAPTEM Chemotherapy in Metastatic Neuroendocrine Tumors with Intermediate MIB1 Index: What Could Be the Molecular Explanation?
Priyanka Sharma and Sandip Basu

Journal of Nuclear Medicine Technology September 1, 2020, 48 (3) 290-291; DOI: https://doi.org/10.2967/jnmt.120.241539
You have access
Combined ¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy and Platinum-Based Chemotherapy in Recurrent, Metastatic Sinonasal Neuroendocrine Carcinoma: A Promising Therapeutic Option
Aadil Adnan and Sandip Basu

Journal of Nuclear Medicine Technology September 1, 2020, 48 (3) 292-294; DOI: https://doi.org/10.2967/jnmt.119.237354
You have access
Rare-Site Primary Soft-Tissue Neuroendocrine Tumor with Metastases and Near-Complete Resolution with ¹⁷⁷Lu-DOTATATE: Documenting a Promising Clinical Application of Peptide Receptor Radionuclide Therapy
Aadil Adnan and Sandip Basu

Journal of Nuclear Medicine Technology March 1, 2020, 48 (1) 36-39; DOI: https://doi.org/10.2967/jnmt.119.227058
You have access
Favorable Response of Metastatic Merkel Cell Carcinoma to Targeted ¹⁷⁷Lu-DOTATATE Therapy: Will PRRT Evolve to Become an Important Approach in Receptor-Positive Cases?
Sandip Basu and Rohit Ranade

Journal of Nuclear Medicine Technology June 1, 2016, 44 (2) 85-87; DOI: https://doi.org/10.2967/jnmt.115.163527